« Return to News | Study Conduct

Network of sites renew with clinicalRSVP participant registry

Thursday, February 23, 2012 02:47 PM

clinicalRSVP, a participant registry that prevents research volunteers from enrolling in overlapping and concurrent research studies, has said all seven original clinicalRSVP user network sites, including Clinical Pharmacology of Miami, Comprehensive Clinical Development, Elite Research Institute and Seaview Research, have agreed to extend their commitment to the clinicalRSVP network through 2012 and beyond.

In 2009, this group of sites was the first in North America to adopt a subject registry to prevent dual enrollment, increasing data integrity and participant safety for their clients. Since inception, the clinicalRSVP network has grown to include 18 phase I units across the U.S. and Canada, representing more than 20% of the North American phase I beds.

The mission of clinicalRSVP is to provide a single North American registry for investigators to confidentially and securely verify subject eligibility requirements prior to enrollment. clinicalRSVP’s features include controls over electronic records, biometric identification safeguarding, operational ease of use and customer support.

“Ensuring our participants’ safety and facilitating rapid study start-up are the primary focuses for us at Comprehensive Clinical Development,” said Dr. Rae DelVecchio, senior vice president, early phase operations. “We want our sponsors and participants to have total confidence in every aspect of our business and clinicalRSVP is a key component of our enrollment process.”

Darran Boyer, president of clinicalRSVP, said, “We feel this recommitment, as well as our continued growth and proven track record, confirms that clinicalRSVP is the premier network that stops dual enrollment.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.